Entrar/Registro  
HOME SPANISH
 
MediSan
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >MediSan >Year 2012, Issue 05


Cuevas MCC, Rodriguez CA, Rodríguez BRP, Romero GLI
Caracterización clinicoepidemiológica de pacientes con hepatitis C en hemodiálisis y factores de pronóstico asociados
MediSan 2012; 16 (05)

Language: Español
References: 19
Page:
PDF: 233.97 Kb.

[Full text - PDF]

ABSTRACT

An observational and analytic case-control study, of all the terminally ill patients with chronic renal failure exposed to purifying treatment with hemodyalisis who didn't suffer hepatitis C at the beginning of the investigation, assisted in "Dr. Juan Bruno Zayas Alfonso" General Hospital in Santiago de Cuba was carried out from January, 2009 to December, 2010, with the objective of characterizing them according to clinical and epidemiological variables of interest and determining the incidence of hepatitis C virus in both study groups, keeping in mind the different prognosis factors. A logistical regression multivariate analysis was applied to identify these factors and the causative influence in the infection by the mentioned virus. Male sex (72.0 %), the age group 45-54 years (21.3 %) and hypertensive (37.3 %) and diabetic (18.7 %) nephropathies prevailed in the series, as the fundamental causes of the disease. Among the main prognosis factors there were the previous hepatic illnesses (OR = 4.80), the exposure to hemoderivatives (OR=1.46) and the reuse of dialysers (OR=1.38).


Key words: hepatitis C virus, terminal chronic renal failure, hemodyalisis, epidemiological risk factor, secondary health care.


REFERENCIAS

  1. Sánchez Tapias JM. Hepatitis crónica por el virus de la hepatitis C. En: Berenguer Lapuerta J. Tratamiento de las enfermedades hepáticas y biliares. Madrid: Asociación Española para el Estudio del Hígado; 2001. p. 41-53.

  2. National Institutes of Health Consensus Conference Statement. Management of Hepatitis C. Hepatology. 2002; 36(5): S1-S20.

  3. Liang MT, Rehermann B, Seeff L, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 2000; 132(4): 296-305.

  4. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 2002. Semin Dial. 2005; 18(1):52-61.

  5. Fissell RB, Bragg Gresaham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004 [citado 12 Ene 2011]; 65(6):2335-42. Disponible en: http://www.nature.com/ki/journal/v65/n6/abs/4494535a.html

  6. Poynard T, Ratzin V, Benmanov, dimartino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis. 2000; 20:47-55.

  7. Margusino F, Suárez L, Martín H. Profilaxis y tratamiento de la hepatopatía por virus C en el entorno del trasplante hepático. Farm Hosp. 2008; 32(2):102-12.

  8. Pérez-Oliva Díaz JR, Magrans Buch C, Almaguer López M, Zambrano Cárdenas AE, Delgado G, Pérez Campo R, et al. Guías de buenas prácticas en hemodiálisis Instituto de Nefrología. La Habana: Instituto Nacional de Nefrología; 2003.

  9. Organización Panamericana de la Salud. Clasificación internacional de enfermedades y otros daños a la salud (CIE-10). Washington, DC: OPS; 2003.

  10. Pezzotti P, Di Lallo D, Petrosillo N, Trivelloni C, Di Giulio S. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region. Am J Kidney Dis. 2006 [citado 12 Ene 2011]; 48(4):629. Disponible en: http://www.ajkd.org/article/S0272-6386%2806%2901163-2/abstract

  11. Saxena AK, Panhotra BR. The vulnerability of midlle-age and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting. J Am Geriatr Soc. 2004; 52(2):242-6.

  12. Sivapalasingam S, Malak SF, Lorch J, Sepkowitz KA. Hingh prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center. Infect Control Hosp Epidemiol.2002; 23 (6):319-24.

  13. Mc Guillian GM, Altr MJ. A population based serologic study of hepatitis C virus infection in the United States viral hepatitis and liver disease. Turin: Minerva Medical;1997.p. 267-70.

  14. Carneiro MA, Martins RM, Teles SA, Silva SA, Lopes CL, Cardoso DD, Vanderborght BO, Yoshida CF. Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Mem Inst Oswaldo Cruz; 2001; 96(6):765-9.

  15. Cieza J, Pinares F, Hinostroza J, Estremadoyro L, Loza C. Factores de riesgo para infección por hepatitis C en dos unidades de diálisis de Lima-Perú. Rev Peruana Med Exp Salud Pública. 2001[citado 12 Ene 2011]; 18(1-2). Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342001000100002

  16. Méndez Chacón P, Vidalón A, Vildosola H. Factores de riesgo de hepatitis C en hemodiálisis y su impacto en la lista de espera para trasplante renal. Rev Gastroenterol Perú. 2005; 25 (1):12-8.

  17. Milián Figueroa IN, Betancourt García M, Dávila Véliz Y. Hepatitis C en pacientes hemodializados: una mirada actual. Revista Médica Electrónica. 2011 [citado 22 Ago 2011]; 33(4). Disponible en: http://www.revmatanzas.sld.cu/revista%20medica/ano%202011/vol4%202011/tema11.htm

  18. Benomar-Haurez A. Traitment actuel de l'hépatite C: Place de la ribavirine. Dossier. 2000; 21(4): 8-45.

  19. Pinto dos Santos J, Loureiro A, Cendoroglo Neto M, Pereira BJG. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant. 1996 [citado 12 Ene 2011];11:2017-22. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/8918716






>Journals >MediSan >Year 2012, Issue 05
 

· Journal Index 
· Links 






       
Copyright 2019